Targeting oncogenic driver mutations in lung cancer:
The recent advances in the field of molecular diagnostic techniques have led to the identification of targetable alterations prompting a paradigm shift in the management of non-small cell lung cancer (NSCLC) and an era of precision oncology. This text highlights the most clinically relevant oncogeni...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Cambridge
Cambridge University Press
2023
|
| Schriftenreihe: | Cambridge elements
|
| Schlagworte: | |
| Online-Zugang: | DE-12 DE-634 DE-92 URL des Erstveröffentlichers |
| Zusammenfassung: | The recent advances in the field of molecular diagnostic techniques have led to the identification of targetable alterations prompting a paradigm shift in the management of non-small cell lung cancer (NSCLC) and an era of precision oncology. This text highlights the most clinically relevant oncogenic drivers other than EGFR, their management and current advancements in treatment. It also examines the different challenges in resistance to targeted therapies and diagnostic dilemmas for each oncogenic driver and the future direction of NSCLC management |
| Beschreibung: | Also issued in print: 2023. - Includes bibliographical references |
| Beschreibung: | 1 Online-Ressource (87 Seiten) Illustrationen |
| ISBN: | 9781009336123 |
| DOI: | 10.1017/9781009336123 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV048824219 | ||
| 003 | DE-604 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 230221s2023 |||| o||u| ||||||eng d | ||
| 020 | |a 9781009336123 |c Online |9 978-1-00-933612-3 | ||
| 024 | 7 | |a 10.1017/9781009336123 |2 doi | |
| 035 | |a (ZDB-20-CBO)CR9781009336123 | ||
| 035 | |a (OCoLC)1371324844 | ||
| 035 | |a (DE-599)BVBBV048824219 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-92 |a DE-634 | ||
| 082 | 0 | |a 616.99424 | |
| 084 | |a XH 5765 |0 (DE-625)152918:13144 |2 rvk | ||
| 100 | 1 | |a Lee, Matthew |d 1980- |0 (DE-588)1281543489 |4 aut | |
| 245 | 1 | 0 | |a Targeting oncogenic driver mutations in lung cancer |c Matthew Lee [and five others] |
| 264 | 1 | |a Cambridge |b Cambridge University Press |c 2023 | |
| 300 | |a 1 Online-Ressource (87 Seiten) |b Illustrationen | ||
| 336 | |b txt |2 rdacontent | ||
| 336 | |b sti |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Cambridge elements | |
| 500 | |a Also issued in print: 2023. - Includes bibliographical references | ||
| 520 | |a The recent advances in the field of molecular diagnostic techniques have led to the identification of targetable alterations prompting a paradigm shift in the management of non-small cell lung cancer (NSCLC) and an era of precision oncology. This text highlights the most clinically relevant oncogenic drivers other than EGFR, their management and current advancements in treatment. It also examines the different challenges in resistance to targeted therapies and diagnostic dilemmas for each oncogenic driver and the future direction of NSCLC management | ||
| 650 | 4 | |a Lungs / Cancer / Treatment | |
| 650 | 4 | |a Cancer / Molecular aspects | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 978-1-00-933613-0 |
| 856 | 4 | 0 | |u https://doi.org/10.1017/9781009336123 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-20-CBO | ||
| 966 | e | |u https://doi.org/10.1017/9781009336123 |l DE-12 |p ZDB-20-CBO |q BSB_PDA_CBO |x Verlag |3 Volltext | |
| 966 | e | |u https://doi.org/10.1017/9781009336123 |l DE-634 |p ZDB-20-CBO |q BTU_PDA_CBO |x Verlag |3 Volltext | |
| 966 | e | |u https://doi.org/10.1017/9781009336123 |l DE-92 |p ZDB-20-CBO |q FHN_PDA_CBO |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1805069254878298112 |
|---|---|
| adam_text | |
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author | Lee, Matthew 1980- |
| author_GND | (DE-588)1281543489 |
| author_facet | Lee, Matthew 1980- |
| author_role | aut |
| author_sort | Lee, Matthew 1980- |
| author_variant | m l ml |
| building | Verbundindex |
| bvnumber | BV048824219 |
| classification_rvk | XH 5765 |
| collection | ZDB-20-CBO |
| ctrlnum | (ZDB-20-CBO)CR9781009336123 (OCoLC)1371324844 (DE-599)BVBBV048824219 |
| dewey-full | 616.99424 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.99424 |
| dewey-search | 616.99424 |
| dewey-sort | 3616.99424 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| discipline_str_mv | Medizin |
| doi_str_mv | 10.1017/9781009336123 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nmm a2200000zc 4500</leader><controlfield tag="001">BV048824219</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">230221s2023 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781009336123</subfield><subfield code="c">Online</subfield><subfield code="9">978-1-00-933612-3</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1017/9781009336123</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-20-CBO)CR9781009336123</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1371324844</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV048824219</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-92</subfield><subfield code="a">DE-634</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.99424</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 5765</subfield><subfield code="0">(DE-625)152918:13144</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Lee, Matthew</subfield><subfield code="d">1980-</subfield><subfield code="0">(DE-588)1281543489</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Targeting oncogenic driver mutations in lung cancer</subfield><subfield code="c">Matthew Lee [and five others]</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge</subfield><subfield code="b">Cambridge University Press</subfield><subfield code="c">2023</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (87 Seiten)</subfield><subfield code="b">Illustrationen</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">sti</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Cambridge elements</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Also issued in print: 2023. - Includes bibliographical references</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The recent advances in the field of molecular diagnostic techniques have led to the identification of targetable alterations prompting a paradigm shift in the management of non-small cell lung cancer (NSCLC) and an era of precision oncology. This text highlights the most clinically relevant oncogenic drivers other than EGFR, their management and current advancements in treatment. It also examines the different challenges in resistance to targeted therapies and diagnostic dilemmas for each oncogenic driver and the future direction of NSCLC management</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lungs / Cancer / Treatment</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer / Molecular aspects</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">978-1-00-933613-0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1017/9781009336123</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-20-CBO</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1017/9781009336123</subfield><subfield code="l">DE-12</subfield><subfield code="p">ZDB-20-CBO</subfield><subfield code="q">BSB_PDA_CBO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1017/9781009336123</subfield><subfield code="l">DE-634</subfield><subfield code="p">ZDB-20-CBO</subfield><subfield code="q">BTU_PDA_CBO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1017/9781009336123</subfield><subfield code="l">DE-92</subfield><subfield code="p">ZDB-20-CBO</subfield><subfield code="q">FHN_PDA_CBO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV048824219 |
| illustrated | Not Illustrated |
| index_date | 2024-07-03T21:34:00Z |
| indexdate | 2024-07-20T04:03:07Z |
| institution | BVB |
| isbn | 9781009336123 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-034089899 |
| oclc_num | 1371324844 |
| open_access_boolean | |
| owner | DE-12 DE-92 DE-634 |
| owner_facet | DE-12 DE-92 DE-634 |
| physical | 1 Online-Ressource (87 Seiten) Illustrationen |
| psigel | ZDB-20-CBO ZDB-20-CBO BSB_PDA_CBO ZDB-20-CBO BTU_PDA_CBO ZDB-20-CBO FHN_PDA_CBO |
| publishDate | 2023 |
| publishDateSearch | 2023 |
| publishDateSort | 2023 |
| publisher | Cambridge University Press |
| record_format | marc |
| series2 | Cambridge elements |
| spelling | Lee, Matthew 1980- (DE-588)1281543489 aut Targeting oncogenic driver mutations in lung cancer Matthew Lee [and five others] Cambridge Cambridge University Press 2023 1 Online-Ressource (87 Seiten) Illustrationen txt rdacontent sti rdacontent c rdamedia cr rdacarrier Cambridge elements Also issued in print: 2023. - Includes bibliographical references The recent advances in the field of molecular diagnostic techniques have led to the identification of targetable alterations prompting a paradigm shift in the management of non-small cell lung cancer (NSCLC) and an era of precision oncology. This text highlights the most clinically relevant oncogenic drivers other than EGFR, their management and current advancements in treatment. It also examines the different challenges in resistance to targeted therapies and diagnostic dilemmas for each oncogenic driver and the future direction of NSCLC management Lungs / Cancer / Treatment Cancer / Molecular aspects Erscheint auch als Druck-Ausgabe 978-1-00-933613-0 https://doi.org/10.1017/9781009336123 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Lee, Matthew 1980- Targeting oncogenic driver mutations in lung cancer Lungs / Cancer / Treatment Cancer / Molecular aspects |
| title | Targeting oncogenic driver mutations in lung cancer |
| title_auth | Targeting oncogenic driver mutations in lung cancer |
| title_exact_search | Targeting oncogenic driver mutations in lung cancer |
| title_exact_search_txtP | Targeting oncogenic driver mutations in lung cancer |
| title_full | Targeting oncogenic driver mutations in lung cancer Matthew Lee [and five others] |
| title_fullStr | Targeting oncogenic driver mutations in lung cancer Matthew Lee [and five others] |
| title_full_unstemmed | Targeting oncogenic driver mutations in lung cancer Matthew Lee [and five others] |
| title_short | Targeting oncogenic driver mutations in lung cancer |
| title_sort | targeting oncogenic driver mutations in lung cancer |
| topic | Lungs / Cancer / Treatment Cancer / Molecular aspects |
| topic_facet | Lungs / Cancer / Treatment Cancer / Molecular aspects |
| url | https://doi.org/10.1017/9781009336123 |
| work_keys_str_mv | AT leematthew targetingoncogenicdrivermutationsinlungcancer |